Scancell gears up for summer data readouts

  • Scancell Holdings PLC (AIMCLP, OTCCNLF) has some big dates on the calendar. July will bring results from the first three groups of its phase II SCOPE trial for advanced melanoma, and it's already started dosing patients in the final group.